Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines

被引:40
作者
Elmasry, Manal S. [1 ,2 ]
Blagbrough, Ian S. [1 ]
Rowan, Michael G. [1 ]
Saleh, Hanaa M. [2 ]
Kheir, Afaf Aboul [2 ]
Rogers, Philip J. [1 ]
机构
[1] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
[2] Zagazig Univ, Dept Analyt Chem, Zagazig, Egypt
关键词
5-Aminosalicylic acid; Aspirin; Mebeverine; Mesalazine; Sulphasalazine; PERFORMANCE LIQUID-CHROMATOGRAPHY; DOSE ADMINISTRATION AIDS; 5-AMINOSALICYLIC ACID; ELECTROCHEMICAL DETECTION; ACETYLSALICYLIC-ACID; HUMAN PLASMA; RAT PLASMA; LC METHOD; STABILITY; VALIDATION;
D O I
10.1016/j.jpba.2010.10.002
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
An HPLC method for the quantitative analysis of mebeverine HCl, 5-aminosalicylic acid (5-ASA), sulphasalazine and dispersible aspirin has been developed and then applied to these specific medicines when stored, with other medications, in Venalink blister packs (monitored dosage system) for periods of up to 35 days. Chromatographic separation was achieved on a reversed-phase C-12 column with an isocratic mixture of methanol, water and acetic acid as the mobile phase. The method was validated regarding: accuracy, precision, detection limits, quantification limits, specificity and robustness. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:646 / 652
页数:7
相关论文
共 30 条
[1]   A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine [J].
Abu-Qare, AW ;
Abou-Donia, MB .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 26 (5-6) :939-947
[2]   Quantitative analysis of mebeverine in dosage forms by HPLC [J].
AlDeeb, O ;
AlHadiya, BM ;
Foda, NH .
CHROMATOGRAPHIA, 1997, 44 (7-8) :427-430
[3]   LC method for the analysis of acetylsalicylic acid, caffeine and codeine phosphate in pharmaceutical preparations [J].
Altun, ML ;
Ceyhan, T ;
Kartal, M ;
Atay, T ;
Özdemir, N ;
Cevheroglu, S .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 25 (01) :93-101
[4]  
[Anonymous], 2008, DRUG SAFETY UPDATE, V1 , P8
[5]  
[Anonymous], 1996, PHARM J, V256, P85
[6]  
[Anonymous], 1992, PHARM J, V248, P174
[7]  
[Anonymous], 1992, PHARM J, V248, P99
[8]  
[Anonymous], 2001, PHARM J
[9]  
[Anonymous], 2008, BRIT PHARM, p[192, 1382]
[10]  
Astbury C., 1988, PHARM BIOMED ANAL, V6, P103